1 Minute read
Partner with us to speed up the development of SNAPP anti-bacterial technology. Explore opportunities for licensing or direct investment.
The technology
University of Melbourne researchers have created star-shaped polypeptides. These are Structurally Nanoengineered Antimicrobial Peptide Polymers, or SNAPPs. They have anti-bacterial properties, including against MDR bacteria.
SNAPPs also have adjuvant activity, improving the efficiency of existing antibiotics.
Market need
Multi-drug resistant (MDR) bacteria are a threat to human health. The development of novel anti-bacterial therapies is a global health priority.
Technology status
Proof-of-concept has been achieved using various in vitro microscopy and bioassay studies. These show SNAPPs’ antimicrobial activity, mode of action and low toxicity.
- Contact
- Shereen Tan
- tan.s@unimelb.edu.au
- +61 3 9035 6020
Banner image: Multi-drug resistant (MDR) bacteria are a threat to human health. Image: Medical illustration of drug-resistant, Neisseria gonorrhoeae bacteria. Photo by US Centers for Disease Control and Prevention (CDC) on Unsplash.
First published on 27 April 2020.
Share this article
Research commercialisation opportunitiesResearch Innovation and Commercialisation
Keep reading
-
Ultra-thin single crystal diamond membrane
Partner with us to develop the fabrication method for single crystal diamond membranes. Explore licensing and/or co-development opportunities.
-
Commercialisation
Discover ways to create impact from your research through commercialisation with the right support, funding and advice.
-
Fast battery charging
This groundbreaking optimised battery charging technology reduces charging times by over 60 per cent and is poised to flip the lithium battery industry on its head.
-
Plasmonic pixel
Partner with us to speed up the adoption of the multispectral plasmonic pixel. Talk to us about licensing or direct investment.